Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2019	$ 859,578	$ 106,742	$ 784,885	$ (32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,856)		(26,856)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	4,142	253	3,889
Stock-based compensation expense	3,960		3,960
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(1,361)	(18)	(1,343)
Other comprehensive income	(72)			(72)
Net earnings	70,091		70,091
Balance at end of period at Jan. 31, 2020	912,050	106,977	837,194	(32,121)
Balance at beginning of period at Oct. 31, 2020	1,114,828	107,583	1,041,507	(34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,411)		(28,411)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	6,229	350	5,879
Stock-based compensation expense	4,516		4,516
Contribution of stock to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(32,292)	(343)	(31,949)
Other comprehensive income	2,086			2,086
Net earnings	111,281		111,281
Balance at end of period at Jan. 29, 2021	$ 1,179,722	$ 107,613	$ 1,104,285	$ (32,176)